Global Blood Glucose Monitoring Devices Market Size is estimated to expand rapidly in the coming years, at a CAGR of 7.4 % from 2018 to 2025. In 2017, the global market valuation was USD 10.5 billion, and it is anticipated to be greater than USD xx.xx billion by 2025. The increasing incidence of diabetes and increasing diabetes-prone geriatric population are the major driving factors for this market. Increasing awareness of diabetes preventative care, launching of new products and supporting government initiatives is also driving the market.

Blood glucose surveillance devices are cost-effective and essential for proper diagnosis and treatment. These devices measure blood sugar and are a key step in the treatment of diabetes. They also help to prevent other conditions of related health, such as neuropathy, retinopathy, and cardiovascular disease. There are different types of monitor blood glucose that vary in size, price, test time and ease of use on the market. Continuing technical developments and the early detection of hypo-glycemic diabetes have benefited the market significantly. Smoking and consuming alcohol and unhealthy foods contribute to rapidly changing lifestyles, which increase the number of patients living with diabetes in the world. Obesity is also one of the main causes of diabetes.

Global Market Growth Opportunities (Revenue, Growth) By 2018-2025

This global market study report analysis offers in-depth insights, revenue details, and other vital information regarding the global blood glucose monitoring devices market, and the various trends, drivers, restraints, opportunities, and threats in the target market till 2025. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global blood glucose monitoring devices market report has been segmented on the basis of type, application, and region. It includes the estimation of the market size, in terms of value, with respect to 4 main geographies, namely, North America, Europe, APAC, and RoW.

Segment Analysis

By End-Use Insights: On the basis of end-use, global blood glucose monitoring devices market has been segmented into hospitals, home care, diagnostic centers.  Due to improved infrastructure and increased health-care expenditure, the hospital sector is expected to lead the market over the forecast period. Moreover, hospitals have a higher cost of measuring blood sugar than home care, thereby generating higher market revenues. Additional provision for the storage and transfer of patient information is available in hospitals.

By Product Insights: On the basis of product, global blood glucose monitoring devices market has been segmented into self & continuous monitoring. Self-monitoring blood glucose (SMBG) gadgets represented the biggest piece of the pie inferable from their convenience and minimal effort. The portion is additionally isolated into blood glucose meters, testing strips, and lancets. The testing strips section represented the overwhelming offer attributable to their high utilization and moderateness. North America has been driving the worldwide market inferable from its settled healthcare department. Expanding commonness of weight and significant expense of treatment is additionally expected to drive the locale, alongside innovative progressions and new item dispatches. Europe is likewise expected to catch a huge piece of the pie over the estimate time frame, because of an expansion in the geriatric populace, which is inclined to diabetes. In addition, upgrades in its medicinal services segment and execution of cutting edge therapeutic items are increasing interest for blood glucose checking gadgets in the district. Asia Pacific is anticipated to be a rewarding district for players. Enhancements in medicinal services offices and repayment strategies in creating economies are key components supporting development in this locale. China led the APAC district in 2018 inferable from its enormous diabetic populace and quick financial development. Moreover, increment in mindfulness in regards to diabetes preventive consideration is further increasing business sector development.

Regional Analysis

The blood glucose monitoring devices market is divided into regions that are North America - U.S, Canada, Other; Asia-Pacific -India, Japan, China, Australia, Other; Europe - UK, Russia, France, Brazil, Other; Middle East and Africa. Every region analysis details in sense of growth, revenue, volume, challenges, and opportunities with the regional and global key players.

Global Blood Glucose Monitoring Devices Market Size, Share Analysis by Region 2018

Global Blood Glucose Monitoring Devices Market Study Objective

1. To forecast the market size of blood glucose monitoring devices market, along with describing and defining the market, in terms of volume and revenue as well as market opportunities for stakeholders, in order to provide a competitive landscape for global market players.

2. Market analysis and forecast of blood glucose monitoring devices market on the basis of region, substrate, and application or end-use industry. To profile major market players, and to analyze their market shares and essential competencies comprehensively.

3. To analyze and elaborate on significant factors that will have a major impact on the growth of blood glucose monitoring devices market, such as drivers, restraints, challenges, and opportunities.

4. The regional analysis of the blood glucose monitoring devices market, to induce market size of five global major regions, which include, Europe, North America, South America, Middle East & Africa, and the Asia Pacific.

5. Strategic analysis of micro-markets, in terms of individual prospects, opportunities, growth trends and their involvement in the overall market.

6. To provide detailed analysis of competitive and strategic developments in the blood glucose monitoring devices market like a new product launch, partnership & agreement, investment & expansion, and company merger & acquisitions.

Key Players Landscape

Abbott Laboratories, Medtronic plc, F. Hoffmann-La Roche Ltd, Bayer AG, Lifescan, Inc., Dexcom, Inc., Sanofi, Eli Lilly and Company, and B Braun Melsungen AG are some of the key players in the market of blood glucose monitoring devices. In order for companies to become marketplaces, they are undertaking strategic initiatives in both developed and developing countries, such as fusions and acquisitions, new product development and risk capital investments. Industries invest in technological solutions to improve distribution, front end sales and service to customers.

Global Blood Glucose Monitoring Devices Market Study Report Offer You!

The global blood glucose monitoring devices market study report gives an idea about market size, share, stock, equity, investment and total price analysis. Also, the report provides comprehensively industry insights with all major factors such as market credit, allocation, demand, distribution, market scope, key players, end-user & applications, provisions, livestock, commodities and industry economics analysis, future growth & forecast. The global market report includes all depth data like pre-market emphasis, market survey, market investment, industry advice, portfolio, finance, access, trade, market exploration, industry review and market predication & projection to develop effective strategies for optimizing their market position.